ADAM9 and glioblastoma: The ADAM9 relevance in the invasive phenotype of GSCs was evaluated in histological samples of GBM patients and orthotopic xenograft models, reporting an elevated co-expression of ADAM9 and TNC in the invasive front of the tumor tissue [90].